LEADER 00000cam  2200000 a 4500 
001    ocn145941858 
003    OCoLC 
005    20081028000000.0 
008    070625t20082008miua     be   001 0 eng   
010      2007026137 
016 7  101475326|2DNLM 
020    9781414429878|q(set 
020    1414429878|q(set 
020    9781414429885|qv. 1 
020    1414429886|qv. 1 
020    9781414429892|qv. 2 
020    1414429894|qv. 2 
035    (OCoLC)145941858 
040    DLC|beng|cDLC|dBAKER|dCDC|dJED|dYDXCP|dDNJ|dVP@|dTSU
       |dBTCTA|dNLM|dCDX|dNOR 
049    GLUA 
050 00 RC437|b.G36 2008 
060 00 WM 13|bG1511 2008 
082 00 616.89003|222 
245 04 The Gale encyclopedia of mental health /|cLaurie J. 
       Fundukian and Jeffrey Wilson, editors. 
246 30 Encyclopedia of mental health 
250    Second edition. 
264  1 Detroit :|bThomson Gale,|c[2008] 
264  4 |c©2008 
300    2 volumes :|bcolor illustrations ;|c29 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
504    Includes bibliographical references and index. 
505 00 |gv. 1.|tA-L --|tAbnormal involuntary movement scale --
       |tAbuse --|tAcupuncture --|tAcute stress disorder --
       |tAddiction --|tAdjustment disorders --|tAdrenaline --
       |tAdvance directives --|tAffect --|tAgoraphobia --
       |tAlcohol and related disorders --|tAlprazolam --
       |tAlzheimer's disease --|tAmantadine --|tAmitriptyline --
       |tAmnesia --|tAmnestic disorders --|tAmoxapine --
       |tAmphetamines --|tAmphetamines and relate disorders --
       |tAnorexia  nervosa --|tAnosognosia --|tAnti-anxiety drugs
       and abuse --|tAntidepressants --|tAntisocial personality 
       disorder --|tAnxiety and anxiety disorders --|tAnxiety 
       reduction techniques --|tApathy --|tAppetite suppressants 
       --|tAprepitant --|tAripiprazole --|tAromatherapy --
       |tAsperger's disorder --|tAssertive community treatment --
       |tAssertiveness training --|tAssessment and diagnosis --
       |tAttention deficit/hyperactivity disorder --|tAutism --
       |tAversion therapy --|tAvoidant personality disorder --
       |tBarbiturates --|tBeck Depression Inventory --|tBehavior 
       modification --|tBender Gestalt Test --|tBenzodiazephines 
       --|tBenztropine --|tBereavement --|tBeta blockers --
       |tBibliotherapy --|tBinge drinking --|tBinge eating --
       |tBiofeedback --|tBiperiden --|tBipolar disorder --|tBody 
       dysmorphic disorder --|tBodywork therapies --|tBorderline 
       personality disorder --|tBrain --|tBreathing-related sleep
       disorder --|tBrief psychotic disorder --|tBulimia nervosa 
       --|tBullying --|tBupropion --|tBuspirone -- 
505 00 |gCaffeine-related disorders --|tCannabis and related 
       disorders --|tCapgras Syndrome --|tCarbamazepine --|tCase 
       management --|tCatatonia --|tCatatonic disorders --|tCATIE
       --|tChamomile --|tChild Depression Inventory --|tChildhood
       disintegrative disorder --|tChildren's Apperception Test -
       -|tChloral hydrate --|tChlordiazepoxide --|tChlorpromazine
       --|tChronic pain --|tCircadian rhythm sleep disorder --
       |tCitalopram --|tClinical Assessment Sales for the Elderly
       --|tClinical trials --|tClomipramine --|tClonazepam --
       |tClonidine --|tClorazepate --|tClozapine --|tCocaine and 
       related disorders --|tCognistat --|tCognitive problem-
       solving skills training --|tCognitive remediation --
       |tCognitive retraining --|tCognitive-behavioral therapy --
       |tCommunication skills and disorders --|tCommunity mental 
       health --|tCompliance --|tCompulsion --|tComputed 
       tomography --|tConduct disorder --|tConner's Rating Scales
       -Revised --|tConversion disorder --|tCo-occurring 
       disorders/Dual diagnosis --|tCouples therapy --|tCovert 
       sensitization --|tCreative therapies --|tCrisis housing --
       |tCrisis intervention --|tCyclothymic disorder -- 
505 00 |tDeinstitutionalization --|tDelirium --|tDelusional 
       disorder --|tDelusions --|tDementia --|tDenial --
       |tDependent personality disorder --|tDepersonalization --
       |tDepersonalization disorder --|tDepression and depressive
       disorders --|tDermatotillomania --|tDesipramine --
       |tDetoxification --|tDevelopmental coordination disorder -
       -|tDiagnosis --|tDiagnostic and Statistical Manual of 
       Mental Disorders --|tDiazepam --|tDiets --
       |tDiphenhydramine --|tDisease concept of chemical 
       dependency --|tDisorder of written expression --
       |tDissociation and dissociative disorders --|tDissociative
       amnesia --|tDissociative fugue --|tDissociative identity 
       disorder --|tDisulfiram --|tDivalproex sodium --
       |tDonepezil --|tDopamine --|tDoxepin --|tDual diagnosis --
       |tDyspareunia --|tDysthymic disorder --|tEcstasy --
       |tElectroconvulsive therapy --|tElectroencephalography --
       |tElimination disorders --|tEncopresis --|tEnergy 
       therapies --|tEnuresis --|tErectile dysfunction --
       |tEstazolma --|tEvening primrose oil --|tExecutive 
       function --|tExercise/Exercise-based treatment --
       |tExhibitionism --|tExposure treatment --|tExpressive 
       language disorder -- 
505 00 |tFactitious disorder --|tFamily education --|tFamily 
       psychoeducation --|tFamily therapy --|tFatigue --|tFeeding
       disorder of infancy or early childhood --|tFemale orgasmic
       disorder --|tFemale sexual arousal disorder --|tFetal 
       alcohol syndrome --|tFatishism --|tFigure drawings --
       |tFluoxetine --|tFluphenazine --|tFlurazepam --
       |tFluvoxamine --|tFrotteurism --|tGabapentin --
       |tGalantamine --|tGanser's syndrome --|tGender identity 
       disorder --|tGender issues in mental health --
       |tGeneralized anxiety disorder --|tGenetic factors and 
       mental disorders --|tGeriatric Depression Scale --
       |tGestalt therapy --|tGinkgo biloba --|tGinseng --|tGrief 
       --|tGrief counseling --|tGroup homes --|tGroup therapy --
       |tGuided imagery therapy --|tHallucinations --
       |tHallucinogens and related disorders --|tHaloperidol --
       |tHalstead-Teitan Battery --|tHamilton Anxiety Scale --
       |tHamilton Depression Scale --|tHare Psychopathy Checklist
       --|tHistorical, Clinical, Risk Management-20 --
       |tHistrionic personality disorder --|tHomelessness --
       |tHospitalization --|tHouse-tree-person test --
       |tHypersomnia --|tHypnotherapy --|tHypoactive sexual 
       desire disorder --|tHypochondriasis --|tHypomania -- 
505 00 |tImaging studies --|tImipramine --|tImpulse-control 
       disorders --|tInformed consent --|tInhalants and related 
       disorders --|tInsomnia --|tIntelligence tests --
       |tIntermittent explosive disorder --|tInternet addiction 
       disorder --|tInternet-based therapy --|tInterpersonal 
       therapy --|tIntervention --|tInvoluntary hospitalization -
       -|tIsocarboxazid --|tJuvenile Bipolar Disorder --
       |tJuvenile depression --|tKaufman Adolescent and Adult 
       Intelligence Test --|tKaufman Assessment Battery for 
       Children --|tKaufman Short Neurological Assessment 
       Procedure --|tKava kava --|tKleine-Levin Syndrome --
       |tKleptomania --|tLamotrigine --|tLate-life depression --
       |tLavender --|tLearning disorders --|tLight therapy --
       |tLithium carbonate --|tLorazepam --|tLoxapine --|tLuria-
       Nebraska Nueropsychological Battery -- 
505 00 |gv. 2.|tM-Z --|tMagnetic resonance imaging --|tMagnetic 
       seizure therapy --|tMajor depressive disorder --|tmale 
       orgasmic disorder --|tMalingering --|tManaged care --
       |tManic episode --|tMaproltiline --|tMarital and family 
       therapists --|tMathematics disorder --|tMatrix model --
       |tMedication-induced movement disorders --|tMeditation --
       |tMemantine --|tMental health courts --|tMental 
       retardation --|tMesoridazine --|tMethadone --
       |tMethamphetamine --|tMethylphenidate --|tMini-mental 
       state examination --|tMinnesota Multiphasic Personality 
       Inventory --|tMirtazapine --|tMixed episode --|tMixed 
       receptive-expressive language disorder --|tModeling --
       |tMolindone --|tMonoamine oxidase inhibitors MAOIs --
       |tMovement disorders --|tMultisystemic therapy --
       |tNaltrexone --|tNarcissistic personality disorder --
       |tNarcolepsy --|tNefazodone --|tNegative symptoms --
       |tNeglect --|tNeuroleptic malignant syndrome --
       |tNeuropsychiatry/Behavioral neurology --
       |tNueropsychological testing --|tNeurosis --
       |tNeurotransmitters --|tNicotine and related disorders --
       |tNightmare disorder --|tNortriptyline --|tNutrition and 
       mental health --|tNutrition counseling -- 
505 00 |tObesity --|tObsession --|tObsessive-compulsive disorder 
       --|tObsessive-compulsive personality disorder --
       |tOlanzapine --|tOpioids and related disorders --
       |tOppositional defiant disorder --|tOrigin of mental 
       illnesses --|tOxazepam --|tPain disorder --|tPanic attack 
       --|tPanic disorder --|tParanoia --|tParanoid personality 
       disorder --|tParaphilias --|tParent management training --
       |tParoxetine --|tPassionflower --|tPathological gambling 
       disorder --|tPaxil and Paxil CR --|tPedophilia --|tPeer 
       groups --|tPemoline --|tPerphenazine --|tPersonality 
       disorders --|tPerson-centered therapy --|tPervasive 
       developmental disorders --|tPhencyclidine and related 
       disorders --|tPhenelzine --|tPhonological disorder --
       |tPica --|tPick's disease --|tPimozide --|tPlay therapy --
       |tPolysomnography --|tPolysubstance dependence --
       |tPositive symptoms --|tPositron emission tomography --
       |tPostpartum depression --|tPost-traumatic stress disorder
       --|tPremature ejaculation --|tPremenstrual Syndrome --
       |tProcess addiction --|tPropranolol --|tProtriptyline --
       |tPseudocyesis --|tPsychiatrist --|tPsychoanalysis --
       |tPsychodynamic psychotherapy --|tPsychologist --
       |tPsychosis --|tPsychosurgery --|tPsychotherapy --
       |tPsychotherapy integration --|tPyromania -- 
505 00 |tQuazepam --|tQuetiapine --|tRage (road rage) --
       |tRational emotive therapy --|tReactive attachment 
       disorder of infancy or early childhood --|tReading 
       disorder --|tReinforcement --|tRelapse and relapse 
       prevention --|tRespite --|tRett's disorder --|tReward 
       deficiency syndrome (RDS) --|tRiluzole --|tRisperidone --
       |tRivastigmine --|tRorschach technique --|tRosemary --
       |tRumination disorder --|tSAMe --|tSchizoaffective 
       disorder --|tSchizoid personality disorder --
       |tSchizophrenia --|tSchizophreniform disorder --
       |tSchizotypal personality disorder --|tSeasonal affective 
       disorder --|tSedatives and related disorders --|tSeizures 
       --|tSelective mutism --|tSelective serotonin reuptake 
       inhibitors (SSRIs) --|tSelf mutilation --|tSelf-control 
       strategies --|tSelf-help groups --|tSeparation anxiety 
       disorder --|tSertraline --|tSexual aversion disorder --
       |tSexual dysfunctions --|tSexual masochism --|tSexual 
       sadism --|tSexual Violence Risk-20 --|tShared psychotic 
       disorder --|tSingle photon emission computed tomography --
       |tSleep disorders --|tSleep terror disorder --
       |tSleepwalking disorder --|tSmoking cessation --|tSocial 
       phobia --|tSocial skills training --|tSocial workers --
       |tSomatization and somatoform disorders --|tSomatization 
       disorder --|tSpecific phobias --|tSpeech-language 
       pathology --|tSt. John's wort --|tStanford-Binet 
       Intelligence Scale --|tStar-D Study --|tSTEP-BD study --
       |tStereotypic movement disorder --|tSteroids --|tStigma --
       |tStress --|tStroke --|tStructured clinical interview for 
       DSM-IV --|tStuttering --|tSubstance abuse and related 
       disorders -- 
505 00 |tSubstance Abuse Subtle Screening Inventory --|tSubstance
       -induced anxiety disorder --|tSubstance-induced psychotic 
       disorder --|tSuicide --|tSupport groups --|tSystematic 
       densensitization --|tTacrine --|tTalk therapy --|tTardive 
       dyskinesia --|tTautomycin --|tTemazepam --|tThematic 
       Apperception Test --|tThioridazine --|tThiothixene --|tTic
       disorders --|tToilet phobia --|tToken economy system --
       |tTranscranial magnetic stimulation --|tTransvestic 
       feishism --|tTranylcypromine --|tTrazodone --|tTreatment 
       for Adolescents with Depression Study --|tTriazolam --
       |tTrichotillomania --|tTriflueoperazine --|tTrihexphenidyl
       --|tTriminpramine --|tUndifferentiated somatoform disorder
       --|tUrine drug screening --|tVaginismus --|tVagus nerve 
       stimulation (VNS) --|tValerian --|tValproic acid --
       |tVascular dementia --|tVenlafaxine --|tVivitrol --
       |tVocational rehabilitation --|tVoyeurism -- 
505 00 |tWechsler Adult Intelligence Scale --|tWechsler 
       Intelligence Scale for Children --|tWernicke-Korsakoff 
       syndrome --|tWide Range Achievement Test --|tYoga --
       |tZaleplon --|tZiprasidone --|tZolphidem. 
650  0 Psychiatry|vEncyclopedias. 
650  0 Mental illness|vEncyclopedias. 
650 12 Mental Disorders|vEncyclopedias|xEnglish. 
700 1  Fundukian, Laurie J.,|d1970- 
700 1  Wilson, Jeffrey,|d1971- 
938    YBP Library Services|bYANK|n2715784 
938    Baker & Taylor|bBKTY|c389.00|d389.00|i1414429878
       |n0007108234|sactive 
938    Baker and Taylor|bBTCP|n2007026137 
938    Coutts Information Services|bCOUT|n3759166 
994    90|bGLU